Click to view your profile
Click to search for condition or expert
Click to open main menu
Pantothenate Kinase-Associated Neurodegeneration Latest Advances
Find the Latest Research About Pantothenate Kinase-Associated Neurodegeneration
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Treatments
Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 02/19/2023
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
See more filters
Deep Brain Stimulation (DBS) with Subthalamic Nucleus (STN) as Target for Pediatric Patients with PKAN.
Condition:
Pantothenate Kinase-Associated Neurodegeneration
Journal:
World neurosurgery
Treatment Used:
Deep Brain Stimulation (DBS) with Subthalamic Nucleus (STN) as Target
Number of Patients:
7
Published:
April 03, 2022
VIEW PUBLICATION
NBIA Syndromes: A Step Forward from the Previous Knowledge.
Journal:
Neurology India
Published:
November 08, 2021
VIEW PUBLICATION
Case-report of neuroacanthocytosis associated with a compound mutation in the VPS13A gene.
Journal:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published:
October 25, 2021
VIEW PUBLICATION
Copper, Iron, and Manganese Toxicity in Neuropsychiatric Conditions.
Journal:
International journal of molecular sciences
Published:
August 07, 2021
VIEW PUBLICATION
Down regulation of the expression of mitochondrial phosphopantetheinyl-proteins in pantothenate kinase-associated neurodegeneration: pathophysiological consequences and therapeutic perspectives.
Journal:
Orphanet journal of rare diseases
Published:
May 06, 2021
VIEW PUBLICATION
Pilot trial on the efficacy and safety of pantethine in children with pantothenate kinase-associated neurodegeneration: a single-arm, open-label study.
Condition:
Pantothenate Kinase-associated Neurodegeneration
Journal:
Orphanet journal of rare diseases
Treatment Used:
Pantethine
Number of Patients:
15
Published:
September 15, 2020
VIEW PUBLICATION
Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study.
Condition:
Pantothenate Kinase-Associated Neurodegeneration
Journal:
The Lancet. Neurology
Treatment Used:
Deferiprone
Number of Patients:
100
Published:
June 17, 2019
VIEW PUBLICATION
Showing 1-7 of 7
Last Updated: 02/19/2023